BTG1.md
... ...
@@ -37,7 +37,7 @@ timeline
37 37
|:------:|:----:|--------------------------------------|
38 38
|![MZL](images/icons/MZL_tier1.png)|1|high-confidence MZL gene|
39 39
|![PMBL](images/icons/PMBL_tier1.png)|1|high-confidence PMBL/cHL/GZL gene[@sarkozyMutationalLandscapeGray2021]|
40
-|![DLBCL](images/icons/DLBCL_tier1.png) |1-EE[@mlynarczykBTG1MutationYields2023b; @delageBTG1InactivationDrives2023a] | aSHM target and high-confidence DLBCL gene [@morinFrequentMutationHistonemodifying2011]|
40
+|![DLBCL](images/icons/DLBCL_tier1.png) |1-EE[@mlynarczykBTG1MutationYields2023; @delageBTG1InactivationDrives2023a] | aSHM target and high-confidence DLBCL gene [@morinFrequentMutationHistonemodifying2011]|
41 41
|![FL](images/icons/FL_tier1.png) |1 | aSHM target and high-confidence FL gene |
42 42
|![BL](images/icons/BL_tier2.png) |2 | aSHM target; Although recurrent, the relevance of mutations in BL is tenuous [@burkhardtClinicalRelevanceMolecular2022]|
43 43